Core Viewpoint - The company reported a significant decline in revenue and net profit for the year 2024, indicating challenges in its operational performance and market conditions [2][3]. Revenue Performance - In 2024, the company achieved revenue of 6.838 billion yuan, a year-on-year decrease of 27.30%, and a net profit attributable to shareholders of 653 million yuan, down 62.62% [2]. - The main brand "汤臣倍健" generated revenue of 3.737 billion yuan, down 30.79%, while the joint care brand "健力多" reported revenue of 808 million yuan, down 31.51% [3]. - The company faced challenges due to a decline in foot traffic at offline pharmacies, product replacement issues, and inventory reduction efforts [3]. Channel Analysis - Revenue from offline channels decreased by 29.79%, with a total of 738 domestic and 49 overseas distributors, a reduction of 200 and 6 respectively compared to the end of 2023 [3]. - Online channel revenue fell by 25.35%, with offline channels experiencing greater pressure due to foot traffic and medical insurance impacts [3]. Cost and Profitability - The gross profit margin for 2024 was 66.69%, down 2.20 percentage points year-on-year, primarily due to intensified competition in online channels [4]. - The sales expense ratio increased to 44.33% for the year, reflecting a decline in sales expenses but a more significant drop in revenue [4]. - The net profit margin for 2024 was 9.47%, down 9.44 percentage points year-on-year, indicating a challenging profitability environment [4]. Strategic Initiatives - The company initiated a promotional campaign focusing on its two core product categories in Q4 2024 and plans to continue a big product strategy in 2025 [5]. - The company aims to launch an OTC version of "健力多" in H2 2025 to meet diverse consumer needs [3][5]. Future Outlook - The company anticipates continued low-price competition in online channels and plans to enhance its core competitiveness while stabilizing offline performance [6]. - Strategies include adjusting expense models, improving product distribution efficiency, and promoting new product iterations [6].

Core Viewpoint - The article emphasizes the strategic planning and operational improvements of Yanjinpuzi, highlighting its transition from a channel-driven model to a product-driven model, which is expected to enhance profitability and market competitiveness [2][3]. Group 1: Strategic Planning and Profitability - Yanjinpuzi has developed a diversified channel structure and successfully built brand categories, which supports mid-term growth through the expansion of key products [2]. - The company is expected to increase its sales expenses in 2024 due to brand building efforts, but a reduction in sales expense ratio is anticipated in 2025 as low-cost channels gain a larger share [2]. - The increase in the proportion of high-margin products is projected to improve the company's net profit margin [2]. Group 2: Product Development and Platform Strategy - Yanjinpuzi has established a replicable success model for key products, particularly in the categories of "Big Devil" and "Egg King," and is advancing towards a platform-based category strategy [3]. - The sales of konjac products are expected to continue increasing, while quail eggs have gained market share despite intense price competition [3]. - The company plans to introduce new deep-sea snack brands and enhance upstream collaborations in fish paste production to strengthen its competitive edge [3]. Group 3: Channel Strategy and Market Expansion - Yanjinpuzi's channel strategy effectively combines market trends with its own capabilities, focusing on high-value membership stores and overseas markets for growth [4]. - The establishment of a separate division for membership stores is aimed at accelerating channel breakthroughs [4]. - The company plans to leverage its konjac products to enter the Southeast Asian market, with local production facilities to reduce transportation costs [4].